Articles by Sarah Chen
CRISPR Therapeutics Shares Slide 11.6% as Casgevy Faces Revenue Test
CRISPR Therapeutics shares fell 11.6% Friday as investors weigh Casgevy's market performance and upcoming governance decisions.
Intellia Shares Surge on Eve of Historic CRISPR Phase 3 Data Release
Intellia Therapeutics shares rallied 19.3% after hours Friday as investors await Phase 3 data from its HAELO trial of lonvoguran ziclumeran, an in vivo CRISPR gene-editing therapy for hereditary angioedema.
OneMedNet Rebounds on Insider Purchases, Palantir Platform Launch
OneMedNet shares climbed back above $1 following $1.5 million in insider purchases and the launch of its Palantir-powered iRWD data platform.
Corning Files Shelf Registration After AI-Driven Stock Surge
Corning filed an automatic shelf registration on Friday, enabling future debt and equity offerings. The move follows a stock surge to $179.08 and precedes its April 28 earnings call.
AAOI Soars 17% on AI Optics Demand, Earnings Test Looms May 7
Applied Optoelectronics shares surged 17.7% to $162.17 on Friday, driven by a $71 million order for 800G transceivers and a Houston expansion. The company's first-quarter earnings report on May 7 will be a key test.
Meta's AWS Graviton5 Deal Signals AI Infrastructure Shift Beyond Nvidia
Meta Platforms has inked a multi-year, multi-billion-dollar agreement with Amazon Web Services to deploy tens of millions of Graviton5 cores for AI workloads, signaling a strategic expansion beyond Nvidia GPUs.
Atomera Surges on Synopsys GaN Chip Modeling Deal
Atomera shares surged 49% to $9.20 after expanding its Synopsys partnership for GaN device modeling, with trading volume exceeding 24 million shares.
Taiwan Eases Stock Limits, TSMC Hits Record High
TSMC shares closed at a record NT$2,185 in Taipei after Taiwan eased single-stock limits for local equity funds and active ETFs, allowing up to 25% investment in the chipmaker.
AEye Surges on Analyst Upgrade as Lidar Turnaround Hopes Grow
AEye surged over 30% after Craig-Hallum initiated coverage with a buy rating and $3.50 target, spotlighting a potential turnaround. The lidar maker faces revenue challenges but adds new operations head.
Snowflake Shares Tumble as AI Initiatives Face Software Sector Headwinds
Snowflake shares dropped 5.5% to $138.42, pressured by a software sector selloff and a class-action deadline. The company is expanding its AI offerings, but investors remain cautious about AI's effect on revenue.
Keel Infrastructure Sells Paraguay Site for $13M, Exits Latin America
Keel Infrastructure sold its Paraguay facility for $13M, less than half the original price, completing its Latin American exit and shift toward AI data centers.
Tempus AI Partners with USC Health System, Unlocking Access to 1.5 Million Annual Visits
Tempus AI Inc. partners with USC's Keck School of Medicine to deploy its molecular testing and trial-matching platform across a health system seeing 1.5 million patient visits each year.